Ngā hua rapu - Yongzheng He
- E whakaatu ana i te 1 - 8 hua o te 8
-
1
Erk1 Positively Regulates Osteoclast Differentiation and Bone Resorptive Activity mā Yongzheng He, Karl Staser, Steven D. Rhodes, Yaling Liu, Xiaohua Wu, Su-Jung Park, Jin Yuan, Xianlin Yang, Xiaohong Li, Li Jiang, Shi Chen, Feng‐Chun Yang
I whakaputaina 2011Artigo -
2
IFATS Collection: The Conditioned Media of Adipose Stromal Cells Protect Against Hypoxia-Ischemia-Induced Brain Damage in Neonatal Rats mā Xing Wei, Zhimei Du, Liming Zhao, Dongni Feng, Gang Wei, Yongzheng He, Jiangning Tan, Wei-Hui Lee, Harald Hampel, Richard Dodel, Brian H. Johnstone, Keith L. March, Martin R. Farlow, Yansheng Du
I whakaputaina 2008Artigo -
3
Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice mā Richa Sharma, Xiaohua Wu, Steven D. Rhodes, Shi Chen, Yongzheng He, Jin Yuan, Jiliang Li, Xianlin Yang, Xiaohong Li, Li Jiang, Edward T. Kim, David A. Stevenson, David Viskochil, Mingjiang Xu, Feng‐Chun Yang
I whakaputaina 2013Artigo -
4
Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation mā Steven D. Rhodes, Yongzheng He, Abbi E. Smith, Jiang Li, Qingbo Lu, Julie A. Mund, Xiaohong Li, Waylan Bessler, Shaomin Qian, William E. Dyer, George E. Sandusky, Andrew Horvai, Amy E. Armstrong, D. Wade Clapp
I whakaputaina 2019Artigo -
5
Loss of Asxl1 leads to myelodysplastic syndrome–like disease in mice mā Jiapeng Wang, Zhaomin Li, Yongzheng He, Feng Pan, Shi Chen, Steven D. Rhodes, Lihn Nguyen, Jin Yuan, Jiang Li, Xianlin Yang, Ophelia Weeks, Ziyue Liu, Jiehao Zhou, Hongyu Ni, Chen‐Leng Cai, Mingjiang Xu, Feng‐Chun Yang
I whakaputaina 2013Artigo -
6
Hyperactive Transforming Growth Factor-β1 Signaling Potentiates Skeletal Defects in a Neurofibromatosis Type 1 Mouse Model mā Steven D. Rhodes, Xiaohua Wu, Yongzheng He, Shi Chen, Hao Yang, Karl Staser, Jiapeng Wang, Ping Zhang, Chang Jiang, Hiroki Yokota, Ruizhi Dong, Xianghong Peng, Xianlin Yang, Sreemala Murthy, Mohamad Azhar, Khalid S. Mohammad, Mingjiang Xu, Theresa A. Guise, Feng‐Chun Yang
I whakaputaina 2013Artigo -
7
Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial mā Michael J. Fisher, Chie‐Schin Shih, Steven D. Rhodes, Amy E. Armstrong, Pamela L. Wolters, Eva Dombi, Chi Zhang, Steven P. Angus, Gary L. Johnson, Roger J. Packer, Jeffrey C. Allen, Nicole J. Ullrich, Stewart Goldman, David H. Gutmann, Scott R. Plotkin, Tena Rosser, Kent A. Robertson, Brigitte C. Widemann, Abbi E. Smith, Waylan Bessler, Yongzheng He, Su Jeong Park, Julie A. Mund, Jiang Li, Khadijeh Bijangi‐Vishehsaraei, Coretta Thomas Robinson, Gary Cutter, Bruce R. Korf, Chie‐Schin Shih, Amy E. Armstrong, Jaishri O. Blakeley, D. Wade Clapp
I whakaputaina 2021Artigo -
8
Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK mā Long‐Sheng Chang, Janet L. Oblinger, Abbi E. Smith, Marc Ferrer, Steven P. Angus, Eric Hawley, Alejandra M. Petrilli, Roberta L. Beauchamp, Lars Björn Riecken, Serkan Erdin, Ming Poi, Jie Huang, Waylan Bessler, Xiaohu Zhang, Rajarshi Guha, Craig J. Thomas, Sarah S. Burns, Thomas S.K. Gilbert, Li Jiang, Xiaohong Li, Qingbo Lu, Jin Yuan, Yongzheng He, Shelley A.H. Dixon, Andrea R. Masters, David R. Jones, Charles W. Yates, Stephen J. Haggarty, Salvatore La Rosa, D. Bradley Welling, Anat Stemmer‐Rachamimov, Scott R. Plotkin, James F. Gusella, Justin Guinney, Helen Morrison, Vijaya Ramesh, Cristina Fernández‐Valle, Gary L. Johnson, Jaishri O. Blakeley, D. Wade Clapp
I whakaputaina 2021Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Biology
Cancer research
Internal medicine
Medicine
Cell biology
Genetics
Endocrinology
In vitro
Neurofibromatosis
Osteoclast
Pathology
Cancer
Gene
Kinase
MAPK/ERK pathway
Neurofibromatosis type 2
Neurofibromin 1
Osteoblast
Progenitor cell
Receptor
Stem cell
Adipose tissue
Adverse effect
Alectinib
Anaplastic lymphoma kinase
Anatomy
Bone marrow
Bone resorption
Brain damage
CDKN2A